0001209191-19-026537.txt : 20190430 0001209191-19-026537.hdr.sgml : 20190430 20190430151759 ACCESSION NUMBER: 0001209191-19-026537 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190430 FILED AS OF DATE: 20190430 DATE AS OF CHANGE: 20190430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Driscoll Martin J CENTRAL INDEX KEY: 0001339402 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37718 FILM NUMBER: 19781083 MAIL ADDRESS: STREET 1: C/O JAVELIN PHARMACEUTICALS, INC. STREET 2: 125 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001566373 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 522386345 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 PARKWOOD DRIVE STREET 2: SUITE 210 CITY: HOPKINTON STATE: MA ZIP: 01748 BUSINESS PHONE: 508-473-5993 X119 MAIL ADDRESS: STREET 1: 35 PARKWOOD DRIVE STREET 2: SUITE 210 CITY: HOPKINTON STATE: MA ZIP: 01748 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-30 0 0001566373 Spring Bank Pharmaceuticals, Inc. SBPH 0001339402 Driscoll Martin J C/O SPRING BANK PHARMACEUTICALS, INC. 35 PARKWOOD DRIVE HOPKINTON MA 01748 1 1 0 0 President and CEO Common Stock 2019-04-30 4 P 0 5000 7.31 A 65400 D Common Stock 2019-04-30 4 P 0 5000 7.36 A 70400 D /s/ Lori Firmani, attorney-in-fact 2019-04-30